— Know what they know.
Not Investment Advice

GTHX NASDAQ

G1 Therapeutics, Inc.
1W: +0.3% 1M: +0.8% 3M: +179.3% 1Y: +379.9% 3Y: -48.7% 5Y: -80.3%
$7.16
Last traded 2024-09-18 — delisted
NASDAQ · Healthcare · Biotechnology · $377.7M mcap · 39M float · 5.56% daily turnover

📊 Key Metrics

TTM
$58M
Revenue
-34.7% YoY
$-45M
Net Income
+45.9% YoY
$-38M
Free Cash Flow
+43.8% YoY
95.6%
Gross Margin
-21.4%
Op. Margin
-33.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-109.0%
ROA-36.3%
ROIC-254.4%

Valuation

P/E-7.7
P/B10.5
EV/EBITDA-3.2

Leverage

Debt/Equity1.95
Current Ratio2.48
Interest Cov.-3.8x

Quality Scores

Piotroski F3/9
Altman Z-10.19
Beneish M-2.24

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms